|
WO2010054285A2
(en)
|
2008-11-10 |
2010-05-14 |
National Health Research Institutes |
Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
|
|
WO2010131921A2
(ko)
*
|
2009-05-14 |
2010-11-18 |
코오롱생명과학 주식회사 |
알킬아민 유도체의 제조방법
|
|
US8221753B2
(en)
|
2009-09-30 |
2012-07-17 |
Tracon Pharmaceuticals, Inc. |
Endoglin antibodies
|
|
EP2722055A1
(en)
*
|
2009-08-17 |
2014-04-23 |
Tracon Pharmaceuticals, Inc. |
Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer
|
|
GB0915515D0
(en)
*
|
2009-09-04 |
2009-10-07 |
Ucl Business Plc |
Treatment of vasculoproliferative conditions
|
|
CN103119047B
(zh)
|
2010-07-23 |
2016-06-15 |
哈佛大学校长及研究员协会 |
三环类蛋白酶体活性增强化合物
|
|
WO2012148889A1
(en)
*
|
2011-04-28 |
2012-11-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitors of human apurinic/apyrimidinic endonuclease 1
|
|
CN102875535B
(zh)
*
|
2011-07-12 |
2016-06-08 |
上海药明康德新药开发有限公司 |
1,5-[(取代)-甲桥]-四氢-1H-吡咯[1,2-c]-咪唑-3(2H)-酮衍生物及制备方法
|
|
EP2806876A4
(en)
*
|
2012-01-25 |
2016-03-02 |
Proteostasis Therapeutics Inc |
Proteasome activity enhancing compounds
|
|
WO2013112706A1
(en)
|
2012-01-25 |
2013-08-01 |
Proteostasis Therapeutics, Inc. |
Proteasome activity modulating compounds
|
|
WO2013144191A1
(de)
|
2012-03-29 |
2013-10-03 |
Bayer Intellectual Property Gmbh |
Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
|
|
CA2873971A1
(en)
|
2012-05-21 |
2013-11-28 |
Bayer Pharma Aktiengesellschaft |
Substituted pyrrolopyrimidines
|
|
UA115789C2
(uk)
|
2012-09-05 |
2017-12-26 |
Трейкон Фармасутікалз, Інк. |
Композиція антитіла до cd105 та її застосування
|
|
EP2961409A1
(en)
*
|
2013-02-26 |
2016-01-06 |
Senex Biotechnology, Inc. |
Inhibitors of cdk8/19 for use in treating estrogen receptor positive breast cancer
|
|
JP6087192B2
(ja)
*
|
2013-04-03 |
2017-03-01 |
京セラ株式会社 |
発電システムおよび発電システムの制御方法ならびに燃料電池
|
|
CN104016983B
(zh)
*
|
2013-10-08 |
2018-11-02 |
上海创诺制药有限公司 |
吡咯并三嗪类衍生物及其制法和用途
|
|
AU2015346444A1
(en)
|
2014-11-12 |
2017-05-04 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
US9926375B2
(en)
|
2014-11-12 |
2018-03-27 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
ES2718175T3
(es)
|
2014-12-02 |
2019-06-28 |
Lilly Co Eli |
Compuestos de 1-oxo-1,2-dihidroisoquinolin-7-il-(tiofen-2-il-5-sustituido)-sulfonamida, formulaciones que contienen esos compuestos, y su uso como inhibidores de AICARFT en el tratamiento de cánceres
|
|
CN104529800B
(zh)
*
|
2014-12-08 |
2017-01-25 |
重庆威鹏药业有限公司 |
反式‑4‑二甲基氨基巴豆酸及盐的制备方法
|
|
WO2016133888A1
(en)
*
|
2015-02-16 |
2016-08-25 |
Biota Pharmaceuticals, Inc. |
Compounds for treating respiratory syncytial virus infections
|
|
US10561749B2
(en)
|
2015-07-03 |
2020-02-18 |
Kyoto University |
Nuclear medicine diagnostic imaging agent
|
|
JP6709552B2
(ja)
*
|
2015-07-03 |
2020-06-17 |
国立大学法人京都大学 |
核医学画像診断薬
|
|
CN108285421A
(zh)
*
|
2018-01-26 |
2018-07-17 |
黑龙江鑫创生物科技开发有限公司 |
一种微通道反应器合成拉帕替尼中间体的方法
|
|
WO2020191151A1
(en)
*
|
2019-03-19 |
2020-09-24 |
Oncovalent Therapeutics Inc. |
Sumo inhibitor compounds and uses thereof
|
|
WO2021041539A2
(en)
*
|
2019-08-28 |
2021-03-04 |
Ferro Therapeutics, Inc. |
Compounds and methods of use
|
|
KR20240044458A
(ko)
*
|
2021-08-05 |
2024-04-04 |
브리스톨-마이어스 스큅 컴퍼니 |
Her2 억제제로서 사용하기 위한 트리시클릭 융합된 피리미딘 화합물
|
|
IL310338A
(en)
*
|
2021-08-31 |
2024-03-01 |
Eisai R&D Man Co Ltd |
Production method for synthetic intermediate of monocyclic pyridine derivative
|
|
CN115724790A
(zh)
*
|
2022-11-21 |
2023-03-03 |
安庆朗坤药业有限公司 |
一种n-(3-氯-4-(2-吡啶甲氧基)苯胺的制备方法
|